Alaunos Therapeutics, Inc. Finance Lease, Liability, Current
Alaunos Therapeutics, Inc. (TCRT) had Finance Lease, Liability, Current of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2024-04-01
- 2023-12-31: Finance Lease, Liability, Current $0.00.
- 2023-09-30: Finance Lease, Liability, Current $307.00K.
- 2023-06-30: Finance Lease, Liability, Current $339.00K.
- 2023-03-31: Finance Lease, Liability, Current $575.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $307.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $339.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $575.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $558.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $542.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $525.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $745.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $729.00K 10-K · filed 2023-03-07 |
| 2020-12-31 | $819.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $866.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $838.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $828.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $774.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $677.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $660.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $644.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |